Endonovo Therapeutics (OTCMKTS:ENDV) Stock Passes Above 50-Day Moving Average – Time to Sell?

Endonovo Therapeutics, Inc. (OTCMKTS:ENDVGet Free Report) crossed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $0.00 and traded as high as $0.00. Endonovo Therapeutics shares last traded at $0.00, with a volume of 32,249,010 shares traded.

Endonovo Therapeutics Stock Down 33.3 %

About Endonovo Therapeutics

(Get Free Report)

Endonovo Therapeutics, Inc, a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema.

Featured Articles

Receive News & Ratings for Endonovo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endonovo Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.